List of Studies ( Metabolite:PE P-40:7 or PE O-40:8)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST002817 | AN004585 | Investigation of metabolism in hypertrophic cardiomyopathy - Lipidomics | Heart | Mouse | Cardiomyopathy | University of California, San Francisco | LC-MS |
| ST002764 | AN004498 | Identification of pre-diagnostic lipid sets associated with liver cancer risk using untargeted lipidomics and chemical set analysis – a nested case-control study within the ATBC cohort | Blood | Human | Cancer | Icahn School of Medicine at Mount Sinai | LC-MS |
| ST001950 | AN003175 | Lipidome Alterations Following Mild Traumatic Brain Injury. | Blood | Rat | Traumatic brain injury | Georgia Institute of Technology | LC-MS |
| ST001888 | AN003059 | A Metabolome Atlas of the Aging Mouse Brain (Study part II) | Brain | Mouse | University of California, Davis | GC-MS/LC-MS | |
| ST001843 | AN002986 | Identification of unique metabolite networks between Latino and Caucasian patients with nonalcoholic fatty liver disease (NAFLD) (part II) | Blood | Human | Fatty liver disease | University of California, Davis | GC-MS |
| ST001843 | AN002986 | Identification of unique metabolite networks between Latino and Caucasian patients with nonalcoholic fatty liver disease (NAFLD) (part II) | Liver | Human | Fatty liver disease | University of California, Davis | GC-MS |
| ST001815 | AN002947 | Metabolic Markers of Methotrexate Response in Juvenile Idiopathic Arthritis | Blood | Human | Arthritis | University of Kansas | GC-MS/LC-MS |
| ST001211 | AN002019 | Metabolomic Markers of Methotrexate Response, In Vitro | Cultured cells | Human | University of Kansas | GC-MS/LC-MS | |
| ST001067 | AN001747 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001067 | AN001747 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001067 | AN001747 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001067 | AN001747 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001745 | Lipidomics analysis for aged mice liver (part-III) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001745 | Lipidomics analysis for aged mice liver (part-III) | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001745 | Lipidomics analysis for aged mice liver (part-III) | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001745 | Lipidomics analysis for aged mice liver (part-III) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001065 | AN001743 | Lipidomics analysis for aged mice brain cortex (part-II) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001065 | AN001743 | Lipidomics analysis for aged mice brain cortex (part-II) | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001065 | AN001743 | Lipidomics analysis for aged mice brain cortex (part-II) | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001065 | AN001743 | Lipidomics analysis for aged mice brain cortex (part-II) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001740 | Lipidomics analysis for aged mice organs | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001740 | Lipidomics analysis for aged mice organs | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001740 | Lipidomics analysis for aged mice organs | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001740 | Lipidomics analysis for aged mice organs | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST000423 | AN000672 | Differences in mycoplasma growth due to different mediums | Cells | Mouse | University of California, Davis | LC-MS | |
| ST000354 | AN000578 | Metabolite comparison of mouse gastric tissue and glands | Stomach | Mouse | University of California, Davis | LC-MS | |
| ST000342 | AN000554 | Renal metabolic pathways indicating ischemic or inflammatory changes | Kidney | Human | Acute kidney injury | University of California, Davis | LC-MS |
| ST000339 | AN000551 | Metabolites in peritoneal macrophages and bone marrow derived macrophages | Cells | Mouse | University of California, Davis | LC-MS | |
| ST000331 | AN000530 | Effects of Zinc on GI tract metabolites (Part 2: Prostate) | Prostate | Mouse | University of California, Davis | LC-MS | |
| ST000330 | AN000528 | Effects of Zinc on GI tract metabolites | Esophagus | Mouse | University of California, Davis | LC-MS | |
| ST000329 | AN000526 | Minimal change disease and focal segmental sclerosis in urine | Urine | Human | Kidney disease | University of California, Davis | LC-MS |
| ST000323 | AN000515 | Progesterone level effects on primary metabolites in uterus, blood, and ovaries (Part 2:Uterine flush) | Uterine fluid | Cow | University of California, Davis | LC-MS | |
| ST000321 | AN000511 | Effects of LGG on current drinkers gut metabolism | Feces | Mouse | Alcoholism | University of California, Davis | LC-MS |
